Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Alaunos Therapeutics, Inc. (TCRT)

Compare
2.1600
+0.7100
+(48.97%)
At close: April 1 at 4:00:01 PM EDT
2.2740
+0.11
+(5.28%)
After hours: April 1 at 7:57:54 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
7
5
2,922
398
--
Operating Expense
7,424
28,498
38,160
77,207
80,361
Operating Income
-7,417
-28,493
-35,238
-76,809
-80,361
Net Non Operating Interest Income Expense
--
-1,921
-3,154
-1,189
--
Other Income Expense
-4,363
-4,726
662
-753
385
Pretax Income
-11,780
-35,140
-37,730
-78,751
-79,976
Net Income Common Stockholders
-11,780
-35,140
-37,730
-78,751
-79,976
Diluted NI Available to Com Stockholders
-11,780
-35,140
-37,730
-78,751
-79,976
Basic EPS
-315.39
-330.00
-25.50
-55.50
-57.00
Diluted EPS
-315.39
-330.00
-25.50
-55.50
-57.00
Basic Average Shares
108.3630
106.6350
1,447.5350
1,429.3270
1,397.5760
Diluted Average Shares
108.3630
106.6350
1,447.5350
1,429.3270
1,397.5760
Total Operating Income as Reported
-12,006
-34,267
-35,105
-77,549
-80,361
Total Expenses
7,424
28,498
38,160
77,207
80,361
Net Income from Continuing & Discontinued Operation
-11,780
-35,140
-37,730
-78,751
-79,976
Normalized Income
-7,191
-29,366
-37,863
-78,011
-79,976
Interest Expense
--
1,921
3,154
1,189
--
Net Interest Income
--
-1,921
-3,154
-1,189
--
EBIT
-11,780
-33,219
-34,576
-77,562
-79,976
EBITDA
-11,536
-30,904
-31,817
-74,965
-78,848
Reconciled Depreciation
244
2,315
2,759
2,597
1,128
Net Income from Continuing Operation Net Minority Interest
-11,780
-35,140
-37,730
-78,751
-79,976
Total Unusual Items Excluding Goodwill
-4,589
-5,774
133
-740
--
Total Unusual Items
-4,589
-5,774
133
-740
--
Normalized EBITDA
-6,947
-25,130
-31,950
-74,225
-78,848
12/31/2020 - 8/24/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PGEN Precigen, Inc.
1.4350
-3.69%
 
INKT MiNK Therapeutics, Inc.
9.22
+6.71%
 
ACTU Actuate Therapeutics, Inc. Common stock
6.70
-1.03%
 
CELU Celularity Inc.
1.7200
-0.58%
 
MNOV MediciNova, Inc.
1.4500
-0.68%
 
CLYM Climb Bio, Inc.
1.2000
-1.64%
 
TOVX Theriva Biologics, Inc.
1.1200
+1.82%
 
GLYC GlycoMimetics, Inc.
0.2011
-4.24%
 
MEIP MEI Pharma, Inc.
2.1500
-1.83%
 
SABS SAB Biotherapeutics, Inc.
1.2302
-8.87%